Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
23.69
-1.36 (-5.43%)
At close: Jun 5, 2026, 4:00 PM EDT
23.69
0.00 (0.00%)
After-hours: Jun 5, 2026, 4:58 PM EDT
Mineralys Therapeutics Employees
Mineralys Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 25 or 49.02% compared to the previous year.
Employees
76
Change (1Y)
25
Growth (1Y)
49.02%
Revenue / Employee
n/a
Profits / Employee
-$1,997,092
Market Cap
1.96B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 25 | 49.02% |
| Dec 31, 2024 | 51 | 23 | 82.14% |
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 600 |
| AbCellera Biologics | 562 |
| Intellia Therapeutics | 377 |
| Pharvaris | 134 |
| Kodiak Sciences | 130 |
| Aurinia Pharmaceuticals | 128 |
MLYS News
- 2 days ago - Mineralys Therapeutics falls -17.1% - TheFly
- 2 days ago - Mineralys Therapeutics falls -12.7% - TheFly
- 2 days ago - Mineralys prices offering of 5.66M shares of common stock at $26.50 - TheFly
- 2 days ago - Mineralys Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 days ago - Mineralys to repurchase future royalty payments in Tanabe license agreement - TheFly
- 2 days ago - Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 2 days ago - Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing - GlobeNewsWire
- 5 days ago - Mineralys Therapeutics presents new data for lorundrostat - TheFly